申请人:Yamanouchi Pharmaceutical Co., Ltd.
公开号:US04758580A1
公开(公告)日:1988-07-19
This disclosure describes compositions of matter useful as growth inhibitors of transplanted tumors in mammals: and this invention discloses a method of inducing the regression and/or palliation of various types of tumors in mammals (mammary cancer, liver cancer, skin cancer, etc.), said method comprising giving to said mammals an effective amount of a compound of the following formula: ##STR1## [wherein A represents an imidazolyl group or a pyridyl group, l represents 0 or 1, m and n each, which may be the same of different, represents an integer of 1 to 6, and, R represents a hydrogen atom or a lower alkyl group], or a salt thereof; the invention also discloses a method of inhibition (or prevention) of metastasis of the various cancers. The above formula compounds have low toxicity, and it is expected to apply various types of administration thereof such as oral administration and parenteral administration. In particular, it is expected that the compounds are useful as new type of medical (anti-cancer) compounds which can be administered orally.
本公开描述了作为哺乳动物移植肿瘤生长抑制剂的物质组合物:本发明揭示了一种诱导哺乳动物各种类型肿瘤(乳腺癌、肝癌、皮肤癌等)退缩和/或缓解的方法,该方法包括向该哺乳动物施用以下式的化合物的有效量:##STR1## [其中A代表咪唑基或吡啶基,l代表0或1,m和n各自,可以相同也可以不同,代表1到6的整数,R代表氢原子或较低的烷基基团],或其盐;该发明还揭示了各种癌症转移的抑制(或预防)方法。上述式的化合物具有低毒性,并预期可以应用各种给药途径,如口服和静脉注射。特别是,预期这些化合物可作为新型口服给药的医用(抗癌)化合物。